Heartgard® Plus for Dogs (22 to 45kg)
For use in dogs to prevent canine heartworm disease by eliminating the tissue stage of heartworm larvae (Dirofilaria immitis) for a month (30 days) after infection and for the treatment and control of ascarids (Toxocara canis, Toxocaris leonina) and hookworms (Ancylostoma caninum, Uncinaria stenocephala, Ancylostoma braziliense).
Heartgard® Plus (ivermectin/pyrantel) should be administered orally at monthly intervals at the recommended minimum dose level of 6mcg of ivermectin per kg and 5mg of pyrantel (as pamoate salt) per kg of body weight.
The recommended dosing schedule for prevention of canine heartworm disease and for the treatment and control of ascarids and hookworms is as follows:
Dog Body Weight: 22kg to 45kg
PREVICOX™ (firocoxib) is a non-steroidal anti-inflammatory drug (NSAID) belonging to the Coxib group which has been selected and developed specifically for veterinary use. As a Coxib it acts by selective inhibition of cyclooxygenase-2 (COX-2)- mediated prostaglandin synthesis while sparing cyclooxygenase-1 (COX-1) – mediated prostaglandin synthesis.
PREVICOX™ has demonstrated at least 350-fold selectivity for COX-2 over COX-1 in in vitro canine whole blood assays. Importantly, no COX-1 inhibition occurs in vitro at levels observed in plasma after therapeutic doses.
• Relief of pain and control of inflammation associated with osteoarthritis and other musculoskeletal disorders.
• Effective control of post-operative pain associated with surgery; including soft tissue, orthopedic and dental procedures.
5mg/kg Once a day, with or without food.
recombinant virus-vectored technology uses only the genetic material that protect against:
• Canine Distemper Virus
• Canine Parvovirus
• Canine Adenovirus Type II
• Canine Parainfluenza Virus
• Canine Coronavirus
• Leptospira canicola
• Leptospira icterohaemorrhagiae
Primary vaccination for puppies:
1st vaccine: 8 weeks of age
2nd vaccine: 12 weeks of age
3rd vaccine: 16 weeks of age
One year later
Triennially for core vaccine
Annually for non-core vaccine